At a recent event organized by that consortium, the New Jersey Alliance for Clinical and Translational Science(NJACTS), leaders from academia, healthcare, government and the pharmaceutical industry discussed the future of scientific and clinical trial innovation in the state. These new innovations will result from a $33-million grant from the National Institutes of Health (NIH). To read the full story.
Recent Posts
- One Rule Change Would Help Tens of Thousands of New Jersey Families Pay for Childcare
- Advanced Models Offer Scientists a Promising Tool to Better Understand Brain Disorders
- NJIT Computing Professor Zhi Wei Named Fellow of AAAS, Follows IEEE Honor.
- Alzheimer’s Early Detection Tests Using Video Games Could Be As Effective as Blood Tests and Boost Clinical Trials.
- Princeton joins new cancer research hub established with gift from Weill Family Foundation.
Categories
- Community (2,240)
- Covid (985)
- CTO Events (6)
- News (2,854)
- Pilots (21)